Core Scientific, Inc. (CORZ) Balance Sheet
CORZ balance sheet, FY2025
September 30, 2025 · U.S. dollars$2.35B assets = $3.31B liabilities + −$962.7M equity
Liabilities exceed assets: shareholders’ equity is negative (−$962.7M).
Both columns are drawn to the same scale: what CORZ owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CORZ financial health
Descriptive bands, not a rating. Fiscal FY2025.
CORZ balance sheet trends, FY2019–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $162.0MFY2019 | $2.35BFY2025 | +56.1%/yr | |
| Total liabilities | $26.2MFY2019 | $3.31BFY2025 | +124.1%/yr | |
| Shareholders’ equity | $135.9MFY2019 | −$962.7MFY2025 | — | |
| Cash & short-term investments | $6.7MFY2019 | $311.4MFY2025 | +89.8%/yr | |
| Total debt | $7.5MFY2019 | $1.06BFY2025 | +128.3%/yr | |
| Net cash (debt) | −$837,000FY2019 | −$748.9MFY2025 | −$748.1M | |
| Working capital | −$8.4MFY2019 | $114.1MFY2025 | +$122.6M | |
| Book value per share | $0.36FY2019 | −$3.03FY2025 | — | |
| Current ratio | 0.57FY2019 | 1.15FY2025 | +0.58 | |
| Debt / equity | 0.06FY2019 | 0.61FY2021 | +0.56 | |
| Shares outstanding | 379.9MFY2019 | 318.1MFY2025 | −2.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CORZ assets
CORZ liabilities and equity
CORZ debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CORZ balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $311.4M | $836.2M | $50.4M | $15.9M | $117.9M | $8.7M | $6.7M |
| Cash & equivalents | $311.4M | $836.2M | $50.4M | $15.9M | $117.9M | $8.7M | $6.7M |
| Short-term investments | — | $23.9M | $2.3M | — | — | — | — |
| Receivables | $337.2M | $1.0M | $7.2M | $257,000 | $1.7M | $1.1M | $287,000 |
| Inventory | $0 | $0 | −$6.2M | $0 | $0 | $58.3M | $0 |
| Other current assets | $247.0M | $66.7M | $45.6M | $69.0M | $637.0M | $2.8M | $4.1M |
| Total current assets | $895.5M | $904.0M | $97.0M | $85.1M | $756.6M | $70.9M | $11.1M |
| Property, plant & equipment (net) | $1.40B | $670.8M | $593.3M | $711.6M | $599.8M | $85.2M | $81.3M |
| Goodwill & intangible assets | $0 | $0 | $2.2M | $1.7M | $1.06B | $64.9M | $62.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $50.3M | $24.0M | $19.6M | $9.3M | $18.6M | $4.5M | $7.4M |
| Total assets | $2.35B | $1.60B | $712.2M | $807.7M | $2.44B | $225.6M | $162.0M |
| Liabilities | |||||||
| Accounts payable | $126.1M | $19.3M | $154.8M | $53.6M | $11.6M | $3.1M | $7.5M |
| Short-term debt | — | $27.9M | $144.2M | — | $104.4M | $18.2M | $2.2M |
| Deferred revenue | $127.6M | $18.1M | $9.8M | — | $141.9M | $44.8M | — |
| Total current liabilities | $781.4M | $134.6M | $488.4M | $186.8M | $320.3M | $69.6M | $19.5M |
| Long-term debt | $1.06B | $1.07B | $684.1M | $0 | $652.2M | $19.9M | $2.1M |
| Lease obligations | $102.2M | $109.5M | $57.1M | $1.5M | $90.6M | $4.4M | — |
| Other long-term liabilities | $1.47B | $1.21B | $136.6M | $1.03B | $125.2M | $2.4M | $4.6M |
| Total liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.10B | $91.9M | $26.2M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $36,000 | — | $27,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$4.15B | −$3.74B | −$2.42B | −$2.17B | −$27.4M | −$74.7M | −$62.5M |
| Accumulated other comprehensive income | — | — | — | — | −$11.0M | $0 | $0 |
| Total shareholders' equity | −$962.7M | −$820.2M | −$596.9M | −$409.3M | $1.34B | $133.7M | $135.9M |
| Key figures | |||||||
| Total debt | $1.06B | $1.20B | $865.5M | — | $818.8M | $40.3M | $7.5M |
| Net cash (debt) | −$748.9M | −$363.6M | −$815.1M | — | −$700.9M | −$31.6M | −$837,000 |
| Working capital | $114.1M | $769.4M | −$391.4M | −$101.7M | $436.3M | $1.3M | −$8.4M |
| Tangible book value | −$962.7M | −$820.2M | −$599.2M | −$411.1M | $277.3M | $68.8M | $73.6M |
| Book value per share | −$3.03 | −$3.21 | −$1.57 | −$1.09 | $5.75 | $0.35 | $0.36 |
| Shares outstanding | 318.1M | 255.8M | 379.9M | 375.2M | 233.3M | 379.9M | 379.9M |
| Current ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | 1.02 | 0.57 |
| Quick ratio | 0.83 | 6.22 | 0.12 | 0.09 | 0.37 | 0.14 | 0.36 |
| Debt / equity | — | — | — | — | 0.61 | 0.30 | 0.06 |
| Equity / assets | −41.0% | −51.3% | −83.8% | −50.7% | 55.0% | 59.3% | 83.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $1.77B | $1.01B | $311.4M | $453.4M | $581.3M | $697.9M | $836.2M | $253.0M | $96.1M | $98.1M | $50.4M | $64.5M |
| Cash & equivalents | $1.77B | $1.01B | $311.4M | $453.4M | $581.3M | $697.9M | $836.2M | $253.0M | $96.1M | $98.1M | $50.4M | $63.9M |
| Short-term investments | — | — | — | — | $172.8M | $80.6M | $23.9M | $783,000 | — | — | $2.3M | $559,000 |
| Receivables | $383.8M | $315.7M | $337.2M | $0 | $250.6M | $1.0M | $1.0M | $6.2M | $4.7M | $1.1M | $7.2M | $2.0M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $1 | $1 | $1 |
| Other current assets | $290.2M | $134.0M | $247.0M | $607.6M | $172.8M | $134.2M | $66.7M | $18.6M | $17.1M | $44.1M | $39.4M | $68.2M |
| Total current assets | $2.44B | $1.45B | $895.5M | $1.06B | $1.00B | $833.2M | $904.0M | $277.9M | $117.9M | $143.3M | $97.0M | $134.7M |
| Property, plant & equipment (net) | $1.89B | $1.45B | $1.40B | $1.19B | $937.2M | $761.5M | $670.8M | $625.2M | $625.8M | $653.7M | $593.3M | $553.9M |
| Goodwill & intangible assets | $228.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.1M | $2.2M | $2.4M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $696.9M | $163.8M | $50.3M | $48.4M | $36.1M | $30.7M | $24.0M | $18.8M | $17.8M | $14.8M | $19.6M | $14.4M |
| Total assets | $5.26B | $3.07B | $2.35B | $2.30B | $1.98B | $1.63B | $1.60B | $921.9M | $761.5M | $814.0M | $712.2M | $705.5M |
| Liabilities | ||||||||||||
| Accounts payable | $112.4M | $218.9M | $126.1M | $212.2M | $215.1M | $6.3M | $19.3M | $6.5M | $8.5M | $16.2M | $154.8M | $45.5M |
| Short-term debt | — | $993.9M | — | — | $12.5M | $27.4M | $27.9M | $27.8M | $26.5M | $29.0M | $144.2M | $148.4M |
| Deferred revenue | $287.2M | $219.6M | $127.6M | $83.7M | $150.1M | $60.9M | $18.1M | $9.9M | $7.9M | $9.2M | $9.8M | $63.2M |
| Total current liabilities | $2.74B | $2.66B | $781.4M | $669.9M | $562.7M | $195.5M | $134.6M | $76.5M | $74.8M | $138.1M | $488.4M | $312.7M |
| Long-term debt | $4.30B | $1.06B | $1.06B | $1.06B | $1.06B | $1.07B | $1.07B | $474.6M | $526.8M | $556.6M | $684.1M | $679.6M |
| Lease obligations | — | — | $102.2M | $102.2M | $103.2M | $106.1M | $109.5M | $75.2M | $75.8M | $75.8M | $57.1M | $57.0M |
| Other long-term liabilities | $641.1M | $651.8M | $1.47B | $1.70B | $1.42B | $539.5M | $1.21B | $1.10B | $1.24B | $437.8M | $136.6M | $132.0M |
| Total liabilities | $7.68B | $4.38B | $3.31B | $3.42B | $3.04B | $1.81B | $2.42B | $1.65B | $1.85B | $1.13B | $1.31B | $1.12B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $36,000 | $36,000 |
| Retained earnings (deficit) | −$5.65B | −$4.49B | −$4.15B | −$4.24B | −$4.09B | −$3.15B | −$3.74B | −$3.47B | −$3.01B | −$2.21B | −$2.42B | −$2.22B |
| Accumulated other comprehensive income | — | — | — | — | $0 | — | — | — | $0 | — | — | — |
| Total shareholders' equity | −$2.42B | −$1.31B | −$962.7M | −$1.13B | −$1.06B | −$181.5M | −$820.2M | −$729.4M | −$1.08B | −$318.5M | −$596.9M | −$418.7M |
| Key figures | ||||||||||||
| Total debt | $4.30B | $2.06B | $1.06B | $1.06B | $1.16B | $1.19B | $1.20B | $567.7M | $620.9M | $655.7M | $865.5M | $864.9M |
| Net cash (debt) | −$2.53B | −$1.05B | −$748.9M | −$605.6M | −$581.1M | −$496.2M | −$363.6M | −$314.7M | −$524.8M | −$557.6M | −$815.1M | −$800.4M |
| Working capital | −$294.1M | −$1.21B | $114.1M | $391.2M | $442.0M | $637.7M | $769.4M | $201.3M | $43.0M | $5.2M | −$391.4M | −$177.9M |
| Tangible book value | −$2.65B | −$1.31B | −$962.7M | −$1.13B | −$1.06B | −$181.5M | −$820.2M | −$729.4M | −$1.08B | −$320.6M | −$599.2M | −$421.2M |
| Book value per share | −$7.44 | −$4.04 | −$3.02 | −$3.54 | −$3.35 | −$0.50 | −$2.68 | −$2.49 | −$3.77 | −$1.13 | −$1.55 | −$1.09 |
| Shares outstanding | 325.3M | 322.9M | 318.3M | 318.6M | 318.0M | 363.3M | 306.1M | 292.5M | 287.5M | 282.5M | 385.1M | 382.5M |
| Current ratio | 0.89 | 0.55 | 1.15 | 1.58 | 1.79 | 4.26 | 6.72 | 3.63 | 1.58 | 1.04 | 0.20 | 0.43 |
| Quick ratio | 0.79 | 0.50 | 0.83 | 0.68 | 1.48 | 3.58 | 6.22 | 3.39 | 1.35 | 0.72 | 0.12 | 0.21 |
| Equity / assets | −46.0% | −42.5% | −41.0% | −49.1% | −53.8% | −11.2% | −51.3% | −79.1% | −142.3% | −39.1% | −83.8% | −59.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 2, 2026); data from EODHD.
CORZ financial position
At the end of fiscal 2025 (September 30, 2025), Core Scientific had total assets of $2.3 billion (up 46.8% from a year earlier), total liabilities of $3.3 billion and shareholders' equity of -$962.7 million. It held $311.4 million in cash and short-term investments against $1.1 billion of debt, net debt of $748.9 million. Its current ratio was 1.15. In the latest quarter (ended June 30, 2026) total assets were $5.3 billion and equity -$2.4 billion.
Related: CORZ income statement, CORZ cash flow statement, CORZ key metrics. See the CORZ stock overview for the latest quote and news.
CORZ balance sheet FAQ
What are Core Scientific's total assets?
Core Scientific reported total assets of $2.3 billion at the end of fiscal 2025 (September 30, 2025), compared with $1.6 billion a year earlier.
How much debt does Core Scientific have?
Core Scientific had $1.1 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Core Scientific have?
Core Scientific held $311.4 million in cash and short-term investments at the end of fiscal 2025; with $1.1 billion of debt that is net debt of $748.9 million.
What is Core Scientific's book value?
Core Scientific's shareholders' equity (book value) was -$962.7 million at the end of fiscal 2025, or −$3.03 per share.
What is Core Scientific's current ratio?
Core Scientific had current assets of $895.5 million and current liabilities of $781.4 million, a current ratio of 1.15 (it can cover its short-term obligations).